Reclaim Your Investment: Join the Fight for Compensation Against Marqeta Inc. (MQ) – Contact Levi Korsinsky Now!

Welcome to the Blog Post Recovering Losses on Your Marqeta, Inc. Investment December 12, 2024 If you find yourself in a situation where you have suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment, you may be eligible for a potential recovery under the federal securities laws. It’s crucial to understand your rights and options…

Read More

ALPI Portugal Chooses BIO-key for Enhanced Security: A Game-Changing Decision for the Logistics Industry

BIO-key International, Inc. Announces Deployment of AuthControl Sentry by ALPI Portugal Lda. MADRID, Spain and HOLMDEL, N.J., Oct. 27, 2023 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) featuring passwordless, phoneless, and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced that ALPI Portugal…

Read More

“Act Now: Protect Your Rights as a Shareholder of GSK PLC – Contact Levi & Korsinsky Before April 7, 2025!”

Investor Alert: GSK plc Faces Class Action Securities Lawsuit What You Need to Know Levi & Korsinsky, LLP has recently notified investors in GSK plc (“GSK” or the “Company”) (NYSE: GSK) of a class action securities lawsuit. This lawsuit aims to recover losses on behalf of GSK investors who were negatively impacted by alleged securities…

Read More

“Unleashing the Power of Recursion: How CDK7 Inhibitors are Making a Splash in the World of Differentiation”

Welcome to the Future of Cancer Treatment Exciting Developments in Cancer Research Today, we’re diving into the fascinating world of cancer research and the groundbreaking advancements being made by a company that is changing the game. This company is advancing REC-617, a revolutionary reversible, non-covalent CDK7 inhibitor that has shown enormous potential in treating advanced…

Read More